Xiaorong Zhong
- Molecular Biology
- Oncology top 5%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging top 10%
- Topics
- Breast Cancer Treatment Studies (31 papers)HER2/EGFR in Cancer Research (17 papers)Advanced Breast Cancer Therapies (12 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Xiaorong Zhong
91 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 546
- Oncology 475
- Cancer Research 452
- Pulmonary and Respiratory Medicine 183
- Radiology, Nuclear Medicine and Imaging 158
Countries citing papers authored by Xiaorong Zhong
This map shows the geographic impact of Xiaorong Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorong Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorong Zhong more than expected).
Fields of papers citing papers by Xiaorong Zhong
This network shows the impact of papers produced by Xiaorong Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorong Zhong. The network helps show where Xiaorong Zhong may publish in the future.
Co-authorship network of co-authors of Xiaorong Zhong
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorong Zhong. A scholar is included among the top collaborators of Xiaorong Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorong Zhong. Xiaorong Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 5 | |
| 11 | 7 | |
| 12 | Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma | 0 |
| 13 | 26 | |
| 14 | 10 | |
| 15 | 95 | |
| 16 | 11 | |
| 17 | 3 | |
| 18 | 19 | |
| 19 | 20 | |
| 20 | 52 |
About Xiaorong Zhong
Xiaorong Zhong is a scholar working on Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 99 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (31 papers), HER2/EGFR in Cancer Research (17 papers) and Advanced Breast Cancer Therapies (12 papers). The work is most often cited by research in Cancer Research (452 citations), Oncology (475 citations) and Molecular Biology (546 citations). Xiaorong Zhong has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Hong Zheng, Ling Deng, Ting Luo, Kunrui Zhu, Hong Bu, Yan Qiu, Ting Luo, Ping He, Bo Fu and Tianjie Pu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.